Raia Drogasil (BSP:RADL3) Long-Term Debt: R$3,236 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:RADL3 Raia Drogasil SA BSP:RADL3
95 GF Score
Price R$18.52
GF Value R$30.02
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Raia Drogasil Long-Term Debt?

Raia Drogasil BSP:RADL3 -0.80% 95 Long-Term Debt is R$3,236 Mil as of Mar. 2026. GuruFocus rates BSP:RADL3 with a GF Score™ of 95/100 and a GF Value™ of R$30.02 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Raia Drogasil's Long-Term Debt for the quarter that ended in Mar. 2026 was R$3,236 Mil.

Raia Drogasil's quarterly Long-Term Debt increased from Sep. 2025 (R$2,760 Mil) to Dec. 2025 (R$3,360 Mil) but then declined from Dec. 2025 (R$3,360 Mil) to Mar. 2026 (R$3,236 Mil).

Raia Drogasil's annual Long-Term Debt increased from Dec. 2023 (R$2,526 Mil) to Dec. 2024 (R$2,657 Mil) and increased from Dec. 2024 (R$2,657 Mil) to Dec. 2025 (R$3,360 Mil).

Raia Drogasil  (BSP:RADL3) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Raia Drogasil Long-Term Debt Related Terms

Raia Drogasil Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Raia Drogasil's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raia Drogasil Long-Term Debt Chart

Raia Drogasil Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 891.39 2,131.55 2,526.10 2,656.82 3,359.62

Raia Drogasil Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,408.49 2,758.64 2,760.12 3,359.62 3,236.09
BSP:RADL3
95GF Score
Raia Drogasil SA BSP:RADL3
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of R$3,236 Mil mean?
Raia Drogasil (BSP:RADL3) has a Long-Term Debt of R$3,236 Mil as of Mar. 2026.
Is Raia Drogasil's Long-Term Debt too high?
Raia Drogasil's current Long-Term Debt is R$3,236 Mil. Overall, Raia Drogasil has a GF Score™ of 95/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raia Drogasil's Long-Term Debt compare to competitors?
Raia Drogasil's Long-Term Debt of R$3,236 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Raia Drogasil's current Long-Term Debt is R$3,236 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raia Drogasil stock overvalued right now?
Based on GuruFocus' analysis, Raia Drogasil (BSP:RADL3) is currently considered Significantly Undervalued. The stock's GF Value™ is R$30.02, compared to a current price of R$18.52 — trading 38.3% below its estimated fair value. The current Long-Term Debt is R$3,236 Mil. Raia Drogasil's overall GF Score™ is 95/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Raia Drogasil (BSP:RADL3), the current Long-Term Debt is R$3,236 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raia Drogasil (BSP:RADL3) Overvalued in 2026?

Based on GuruFocus' analysis, Raia Drogasil stock appears to be undervalued. The current stock price of R$18.52 is trading 38.3% below its estimated GF Value™ of R$30.02. GuruFocus considers Raia Drogasil to be Significantly Undervalued.

Key valuation signals for BSP:RADL3:

  • Long-Term Debt: R$3,236 Mil
  • GF Value™: R$30.02 vs. price of R$18.52 (38.3% below fair value)
  • GF Score™: 95/100 with 3 warning signs

No single metric tells the full story. See the BSP:RADL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Raia Drogasil Business Description

Other Exchanges RADLY:USA
Address Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-900
Raia Drogasil SA operates a chain of pharmacies in Brazil. The company is mainly engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its pharmacies mainly operate under the Drogasil and Raia brands.
95GF Score

Get the complete analysis for BSP:RADL3

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$18.52
Price
R$30.02
GF Value